Discover how Prof. Romain Eschalier and Dr. @DrGarot perform AF ablation with Farapulse and Watchman FLX in a single session. Module #2: Advancing Stroke Prevention with OPTION Trial. Learn how: #StrokePrevention #LAAC #OPTIONTrial

FARAPULSE™: Largest #PFA trial portfolio, 200K+ patients treated, 150+ publications, and 0.98% major adverse event rate (MANIFEST-17K). #ClinicalEvidence you can trust. ​.See the data: #Epeeps

Achieve predictable ZERO EXCHANGE left heart access with the VersaCross Connect™ Access Solution for FARADRIVE™, engineered to integrate seamlessly into your FARAPULSE™ #PFA System procedural workflow. Learn more: #Epeeps #Afib #MedEd.

Watch the full interview with Prof. @DanielScherr3 as he shares insights for new operators and explains how integrating imaging and #EPmapping can enhance clinical outcomes. Watch now: #Epeeps #MedEd

How does FARAPULSE™ #PFA compare to #thermal ablation? ​. It significantly reduced AA burden, meaning lower risk of redo ablation, cardioversion, and hospitalization, with better quality of life. #MedEd #PulsedFieldAblation #AFib #Ablation

Another successful OPTION case at Hospital de Valme, Seville!. AF ablation was performed by Dr. Pavón Jiménez and Dr. Romero Garrido (EP), and the LAAC procedure by Dr. @pastorluisps and Dr. Sánchez Burguillos (IC). Learn more: #OPTIONTrial

PFA Key Topics — a new series of concise, expert-led capsules exploring the science behind #PFA .📍Capsule 1: Haemolysis in PFA. 🔹 Why it happens. 🔹 Biomarkers to track. 🔹 Workflow-related risks. 🔹 Latest #ClinicalData. 📎Watch: #MedEd

Introducing the VersaCross Connect™ Access Solution for POLARSHEATH™,for zero exchange #transseptal to POLARSHEATH Steerable Sheath delivery. Learn how you can simplify left heart access for POLARx™ Cryoablation procedures: #Epeeps #CardioEd #CardioX

The IVUS Challenge is a success at #MLCTO2025!. Thank you to all the physicians taking part and helping make it a truly enriching experience. If you haven’t tried it yet, there’s still time to join the challenge at our booth. #BSCEMEA #ModernPCI

Discover workflows tips to boost durability and reduce fluoroscopy time: #MedicalEducation #MedicalTraining.

#Epeeps, Is integrated #Mapping just for complex cases?. Dr Sandrine Venier shares insights from their first 100 procedures with FARAVIEW™ compared to 1000 procedures with FARAPULSE™. #Afib #PFA #MedEd #MedTwitter

Watch the full video: #ClinicalPractice #MedTwitter.

Discover the future of #PulsedFieldAblation and emerging technologies! . Join Prof. @SergeBoveda as he explores the potential of FARAVIEW™ and its impact on his daily practices. #Epeeps #Afib #PFA

#Epeeps, discover the full potential of VersaCross Connect™: Prof. Széplaki explains how it integrates with our FARADRIVE™ Steerable Sheath for a zero-exchange workflow, enhancing efficiency and safety in #PFA procedures.​ . #MedEd #MedTech

Lesion Characteristics from Different Basket Poses in Pre-clinical model. Dr Jacob Koruth @jskoruth explains acute vs chronic lesions and why full tissue coverage matters for durability. Discover more here: #Epeeps #MedTwitter #MedClips #EPMapping

Experience consistent workflows and enhanced operational efficiency with the leading PFA system, now integrated with the FARAVIEW™ Software Module. Learn about the benefits of the FARAVIEW™: #PulsedFieldAblation #PFA #Epeeps

Streamline left heart access for WATCHMAN FLX™ procedures. The VersaCross Connect™ LAAC Access Solution works with the WATCHMAN FXD Curve™ Access System for zero exchange #transseptal to WATCHMAN™ Sheath delivery. Learn more now!.

🔗Watch the session here: #EP.

What happens after a #PFA pulse?. Dr Tomás García Sánchez shows how PFA affects target and surrounding cells creating temporary, reversible changes that may recover conduction. 💡Visual lesions breakdown & tips for long-term durability. #MedEd #MedicalTraining #Epeeps

🚀 ADVANTAGE Phase II shines! 🚀.3-month safety: 2.4% event rate, no PV stenosis/esophageal fistula. [97.5% UCL = 5.2%].12-month effectiveness: 73.4% event-free rate. FARAPOINT Catheter: 96.4% CTI success. FARAPULSE™ transforms PersAF treatment. Stay tuned!.#AFib #Innovation.